Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
BALA CYNWYD, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management team will present and participate in 1x1 investor meetings at the following upcoming investor conferences taking place in Miami Beach, FL.
Presentation details can be found below.
Leerink Partners Global Healthcare Conference
Date: Tuesday, March 10, 2026
Time: 8:40 AM ET
Webcast Link:
The Citizens Life Sciences Conference
Date: Wednesday, March 11, 2026
Time: 4:00 PM ET
Webcast Link:
Following the conclusion of the presentations, a replay will be available for 30 days on the “Events and Presentations” page of Larimar’s website.
About Larimar Therapeutics
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's ataxia. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: .
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
XPO's 0.42% Drop and 301st Place in Trading Volume Suggest Uncertainty in Earnings as Guidance Remains Mixed
Sherwin-Williams Shares Fall 0.33 as Trading Volume Drops 25.17 to $0.44 Billion Ranking 280 in Market Activity
Cadence Design Systems (CDNS) Outperforms Broader Market: What You Need to Know
RTX (RTX) Surpasses Market Returns: Some Facts Worth Knowing
